Distribution of SPARC during neovascularisation of degenerative aortic stenosis
- Laval Hospital Research Center/Quebec Heart Institute, Department of Surgery, Laval University, Ste-Foy, Quebec, Canada
- Correspondence to:
Dr Patrick Mathieu
Laval Hospital, 2725 Chemin Ste-Foy, Sainte-Foy, Quebec, Canada G1V 4G5;
- Accepted 9 May 2006
- Published Online First 18 May 2006
Objective: To examine the hypothesis that degenerative aortic stenosis (AS) is associated with the development of blood vessels and the expression of the secreted protein, acidic and rich in cysteine/osteonectin (SPARC), a matricellular protein that is involved in ossification, the modulation of angiogenesis and the production of metalloproteinases.
Methods: 30 surgically excised AS valves and 20 normal aortic valves were studied.
Results: Blood vessels were detected in the aortic valves from patients with degenerative AS, whereas normal valves were avascular structures. Blood vessels in AS valves expressed endothelial nitric oxide synthase, CD34 and von Willebrand factor (vWF). Blood vessels were located in three distinct regions: near calcified nodules, under the leaflet border and in rich cellular areas forming cell islands. Blood vessels were predominantly present in early and intermediate grades of calcification. Cell islands were densely populated by CD45-positive cells where endothelial cells (CD34+, vWF+) forming cord-like structures were present. Immunoblotting detected SPARC only in AS valves and immunohistological analysis located SPARC in mature blood vessels. The proportion of blood vessels positive for SPARC was higher in valves with a lower grade of calcification. In cell islands, SPARC was distributed to mature blood vessels and to macrophages, where it co-located with matrix metalloproteinase-9, whereas no expression was detected in endothelial cells forming cord-like structures.
Conclusion: The localisation of SPARC to mature blood vessels and its predominant expression in AS valves with a lower calcification grade suggest that the spatial and temporal distribution of this matricellular protein is tightly controlled to participate in the neovascularisation of AS valves.
- AS, aortic stenosis
- eNOS, endothelial nitric oxide synthase
- EPS, endothelial progenitor cells
- MMP-9, matrix metalloproteinase-9
- SPARC, secreted protein, acidic and rich in cysteine/osteonectin
- vWF, von Willebrand factor
Published Online First 18 May 2006
PP holds the Canada Research Chair in Valvular Heart Diseases, Canadian Institutes of Health Research, Ottawa, Ontario, Canada
This work was supported by the Quebec Heart Institute Foundation